Northwest Oncology & Hematology Partners with Canopy
New Partnership Will Further Enhance Operations for Continuous Care Management
Read moreNew Partnership Will Further Enhance Operations for Continuous Care Management
Read moreNew Partnership Will Further Enhance Patient Outcomes Through Continuous Care Management New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, today announced a partnership with Canopy, the first Intelligent Care Platform for oncology, to further enhance patient outcomes through continuous care management. NYCBS officially launched the Canopy Platform after a rapid implementation.
Read moreCanopy, the first Intelligent Care Platform for oncology, today announced its commitment to CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).
Read moreNew Partnership Helps Optimize Care Management Programs and Remote Care Delivery Hawaii Cancer Care has partnered with Canopy, the first Intelligent Care Platform for oncology, to further transform patient outcomes and experiences through continuous care delivery and the implementation of a value-based program, Principal Care Management (PCM).
Read more.png.avif)
40 Under 40 in Cancer recognizes contributions made across the field of cancer by rising stars and emerging leaders. NEW YORK—Canopy, the first Intelligent Care Platform for oncology, today announced that Canopy Founder and CEO Lavi Kwiatkowsky was selected as a recipient of the 40 Under 40 in Cancer Award.
Read more
21-Month Study Demonstrates the Impact of ePROs in Identifying Patients at Risk of Early Treatment Discontinuation New York, New York - Canopy, the first Intelligent Care Platform for oncology, today announced results from a 21-month, real-world study demonstrating that electronic patient-reported outcomes (ePROs) can help identify common side effects in lung cancer patients receiving immunotherapy, both as monotherapy and in combination with chemotherapy. The Identification of key symptomatic differences in patients with shorter duration of therapy could suggest that aggressive early management can extend time on therapy, leading to improved outcomes.
Read more
Jan 01 2023

Nov 07 2022

Sep 06 2022

Mar 19 2022

Mar 18 2022

Mar 17 2022

Mar 17 2022